Published in Cancer Weekly, February 2nd, 2010
This research service provides the market overview, market trends, patient and revenue forecasts for colorectal cancer in the U.S. from 2006-2016. The patient population and revenue forecasts are discussed in terms of staging and line of therapy. This includes in-depth analysis of the market segmented by line of therapy providing competitive information and pipeline analysis. This research service also captures results from the Frost & Sullivan "Voice of the Customer"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.